Brief report · 30 Mar 2026
Case reportPublished 31 Dec 2022
A Possible Case of Acquired Hemophilia Following COVIDandminus;19 Vaccination
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
COVID-19 vaccination has been very efficient in preventing severe illness and death from SARS CoV-2. These vaccines are usually reported to have mild and transient side effects. We report a case of a 59-year-old woman with an acquired hemophilia A following the administration of her second dose of mRNA 1273 vaccine. The patient presented with worsening swelling and bruising of her left arm three days after vaccination. She had a history of COVID-19 infection 3 months ago. Laboratory workup showed elevated partial thromboplastin time (PTT) and mixing study showed possible inhibitor. Factor VIII level (%) was <5% and the inhibitor panel confirmed presence of inhibitor. The patient was treated with high dose steroids and cyclophosphamide. Currently the patient is on slow taper steroids and hematoma has improved.
Subjects
General & Internal MedicineAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Clinical Case Reports.
Opinion · 30 Mar 2026
Atypical Multiple Sclerosis in Young Adults: Challenges and Management
Brief report · 30 Mar 2026
Stress-Induced Heart Failure: The Mind-Heart Connection
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Clinical Case Reports
- SubjectGeneral & Internal Medicine
- BylineArticles whose byline prints “Kanak Parmar”
- BylineArticles whose byline prints “Shivam Singh”
- BylineArticles whose byline prints “Robert Horn”
- BylineArticles whose byline prints “Udit Verma”
